Now Reading
Alkermes Awarded 2023 Platinum Bell Seal for Workplace Mental Health
Alkermes Awarded 2023 Platinum Bell Seal for Workplace Mental Health
Published 07-25-23
Submitted by Alkermes
Alkermes is honored to be selected for the Bell Seal for Workplace Mental Health at Platinum for the second consecutive year. This award, given annually by Mental Health America recognizes our commitment to fostering a mentally healthy workplace.
As a company with a long history of supporting people affected by serious mental illness and addiction, mental health is woven into the very fabric of who we are as an organization. We believe that by investing in and implementing policies and practices to support our employees’ physical and mental well-being, we can create a safe, healthy, and supportive environment where everyone can thrive.
Read more about this honor: https://lnkd.in/eYQzUXuX
Alkermes
Alkermes
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
More from Alkermes
